BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? (Q38324210)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

review article

1 reference

title

BNP in children with congenital cardiac disease: is there now sufficient evidence for its routine use? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

0 references

1 reference

Massimiliano Cantinotti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Massimiliano Cantinotti

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

7

Aldo Clerico

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

6

Bruno Murzi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

4

Maura Crocetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

5

Marco Marotta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Henry L Walters

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

publication date

20 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

published in

Cardiology in the Young

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

424-437

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

The influence of percutaneous closure of patent ductus arteriosus on left ventricular size and function: a prospective study using two- and three-dimensional echocardiography and measurements of serum natriuretic peptides.

28 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide to predict ductus intervention in infants <28 weeks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Pulse oximetry with clinical assessment to screen for congenital heart disease in neonates in China: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Diagnostic role of plasma BNP levels in neonates with signs of congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Abnormal tissue doppler images are associated with elevated plasma brain natriuretic peptide and increased oxidative stress in acute Kawasaki disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma B-type natriuretic peptide levels in children with heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Role of plasma B-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide in paediatric patients with congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Increased natriuretic peptide type B level after the second palliative step in children with univentricular hearts with right ventricular morphology but not left ventricular morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Are serial BNP measurements useful in heart failure management? Serial natriuretic peptide measurements are useful in heart failure management

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Clinical relevance of biological variation of B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Hypoxia induces B-type natriuretic peptide release in cell lines derived from human cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Natriuretic peptides in unstable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Natriuretic peptides and myocardial ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Fibrosis rather than blood pressure determines cardiac BNP expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Angiotensin II-Induced Ventricular Hypertrophy and Extracellular Signal-Regulated Kinase Activation Are Suppressed in Mice Overexpressing Brain Natriuretic Peptide in Circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Ventricular production of natriuretic peptides and ventricular structural remodeling in hypertensive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Brain-type natriuretic peptide at birth reflects foetal maturation and antenatal stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Pediatric brain natriuretic peptide concentrations vary with age and sex and appear to be modulated by testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The future of neonatal therapeutic trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Ethical challenges in neonatal research: Summary report of the ethics group of the newborn drug development initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Natriuretic peptides as biomarkers in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Pediatric brain natriuretic peptide and N-terminal pro-brain natriuretic peptide reference intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Old and new biomarkers of heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Reference values for plasma B-type natriuretic peptide in the first days of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Normal values of B type natriuretic peptide in infants, children, and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Echocardiographic parameters and brain natriuretic peptide in patients after surgical repair of tetralogy of Fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Tissue Doppler imaging and brain natriuretic peptide levels in adults with repaired tetralogy of Fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

NT-pro-B-type natriuretic peptide in infants and children: reference values based on combined data from four studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Amino-terminal fragment of pro-brain natriuretic hormone identifies functional impairment and right ventricular overload in operated tetralogy of Fallot patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma levels of B-type natriuretic peptide in patients with tetralogy of Fallot after surgical repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Systematic differences between BNP immunoassays: comparison of methods using standard protocols and quality control materials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Evaluation of right ventricular function by using tissue Doppler imaging in patients after repair of tetralogy of fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Elevated brain natriuretic peptide and reduced exercise capacity in adult patients operated on for tetralogy of fallot is due to biventricular dysfunction as determined by the myocardial performance index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Performance characteristics of four automated natriuretic peptide assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Brain natriuretic peptide and magnetic resonance imaging in tetralogy with right ventricular dilatation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma soluble corin in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Functional analysis of the transmembrane domain and activation cleavage of human corin: design and characterization of a soluble corin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Right ventricular dysfunction and B-type natriuretic peptide in asymptomatic patients after repair for tetralogy of Fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Ectodomain shedding and autocleavage of the cardiac membrane protease corin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Reduced contractile reserve of the systemic right ventricle under Dobutamine stress is associated with increased brain natriuretic peptide levels in patients with complete transposition after atrial repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Processing of pro-B-type natriuretic peptide: furin and corin as candidate convertases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Angiotensin receptor blockade and exercise capacity in adults with systemic right ventricles: a multicenter, randomized, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Hot topics in tetralogy of Fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

N-terminal pro-brain natriuretic peptide as a predictor of reoperation in children with surgically corrected tetralogy of fallot

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma N-terminal pro-B-type natriuretic peptide concentrations in a control population of infants and children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

A prospective, randomized, double-blind, placebo controlled trial of beta-blockade in patients who have undergone surgical correction of tetralogy of Fallot.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

N-terminal pro-brain natriuretic peptide as a marker in follow-up patients with tetralogy of Fallot after total correction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Plasma Concentrations of Aminoterminal Pro Atrial Natriuretic Peptide and Aminoterminal Pro Brain Natriuretic Peptide in Healthy Neonates: Marked and Rapid Increase After Birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Relation of systemic ventricular function quantified by myocardial performance index (Tei) to cardiopulmonary exercise capacity in adults after Mustard procedure for transposition of the great arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Relation of physical activity, cardiac function, exercise capacity, and quality of life in patients with a systemic right ventricle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The precursor to B-type natriuretic peptide is an O-linked glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Characterization of molecular forms of probrain natriuretic peptide in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Molecular forms of human brain natriuretic peptide in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The diagnostic and prognostic value of brain natriuretic peptides in adults with a systemic morphologically right ventricle or Fontan-type circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The paradox of increased natriuretic hormones in congestive heart failure patients: does the endocrine heart also fail in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Brain natriuretic peptide as a biomarker of systemic right ventricular function in patients with transposition of great arteries after atrial switch operation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Simultaneous assessment of unprocessed ProBNP1-108 in addition to processed BNP32 improves identification of high-risk ambulatory patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Value of N-terminal pro brain natriuretic peptide levels in different types of Fontan circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Hemodynamic characteristics of cyanotic adults with single-ventricle physiology without Fontan completion

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Association of impaired linear growth and worse neurodevelopmental outcome in infants with single ventricle physiology: a report from the pediatric heart network infant single ventricle trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Assay for measurement of intact B-type natriuretic peptide prohormone in blood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

ProBNP-derived peptides in cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Clinical profiles of adult patients with single ventricular physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Evidence for functional heterogeneity of circulating B-type natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The architecture of diagnostic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in fontan patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Neurohormonal activation late after cavopulmonary connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Factors associated with serum brain natriuretic peptide levels after the Fontan procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Usefulness of various plasma biomarkers for diagnosis of heart failure in children with single ventricle physiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The syndrome of cardiac failure in adults with congenitally corrected transposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Biomarker responses during mid-term mechanical cardiac support in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Usefulness of B-type natriuretic peptide as a noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Cardiac transplantation affects ventricular expression of brain natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide in children after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Age- and disease-related variations in B-type natriuretic peptide response after pediatric cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide levels predict outcomes in infants undergoing cardiac surgery in a lesion-dependent fashion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide: perioperative patterns in congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Impact of cardiac surgery on plasma levels of B-type natriuretic peptide in children with congenital heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Utility of N-terminal brain natriuretic peptide plasma concentrations in comparison to lactate and troponin in children with congenital heart disease following open-heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Time course and prognostic value of plasma B-type natriuretic peptide concentration in neonates undergoing the arterial switch operation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Alterations in plasma B-type natriuretic peptide levels after repair of congenital heart defects: a potential perioperative marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

B-type natriuretic peptide levels predict outcome after neonatal cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Controversies in the definition and management of insignificant left-to-right shunts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Urinary NT-proBNP, NGAL, and H-FABP may predict hemodynamic relevance of patent ductus arteriosus in very low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Functional anatomy of tricuspid regurgitation in patients with systemic right ventricles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

Reference intervals for brain natriuretic peptide in healthy newborns and infants measured with an automated immunoassay platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Acute myocardial hypoxia increases BNP gene expression.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Increased Plasma Pro-B-Type Natriuretic Peptide in Infants of Women with Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Comparison of mass spectrometry and clinical assay measurements of circulating fragments of B-type natriuretic peptide in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Serum markers of systemic right ventricular function and exercise performance

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Aminoterminal brain natriuretic peptide levels in children and adolescents after Fontan operation correlate with congestive heart failure

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Discordant expression of pro-B-type and pro-C-type natriuretic peptide in newborn infants of mothers with type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Clinical research in newborn infants: difficulties and specificity

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

N-Terminal pro-brain natriuretic peptide: normal ranges in the pediatric population including method comparison and interlaboratory variability

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Assessment of myocardial function in pediatric patients with operated tetralogy of Fallot: preliminary results with 2D strain echocardiography

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Usefulness of exercise-induced changes in plasma levels of brain natriuretic peptide in predicting right ventricular contractile reserve after repair of tetralogy of Fallot

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Early detection of cardiac dysfunction by BNP in beta-thalassaemia major patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

B-type natriuretic peptide levels in congenital heart disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Amino-terminal pro-brain-type natriuretic peptide: heart or lung disease in pediatric respiratory distress?

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Exercise induces biventricular mechanical dyssynchrony in children with repaired tetralogy of Fallot

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Prognostic value of B-type natriuretic peptide in surgical palliation of children with single-ventricle congenital heart disease

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Thyroid and brain natriuretic Peptide response in children undergoing cardiac surgery for congenital heart disease- age-related variations and prognostic value.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Pathophysiological and clinical relevance of circulating levels of cardiac natriuretic hormones: are they merely markers of cardiac disease?

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Natriuretic peptides correlate between newborn twins but not between twins and their mothers

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

The use of a bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Human pro-B-type natriuretic peptide is processed in the circulation in a rat model

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Relation of diastolic and systolic function, exercise capacity and brain natriuretic peptide in adults after Mustard procedure for transposition of the great arteries

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Immunodetection of glycosylated NT-proBNP circulating in human blood

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

The relationship of systemic right ventricular function to ECG parameters and NT-proBNP levels in adults with transposition of the great arteries late after Senning or Mustard surgery

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

N-terminal pro-B-type natriuretic peptide and its relationship with cardiac function in adults with congenital heart disease.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

B-type natriuretic peptide in patients with systemic right ventricle

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Brain natriuretic peptide assessed at long-term follow-up before and after maximal exercise in surgically palliated patients with functionally univentricular hearts

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Plasma brain natriuretic peptide and systemic ventricular function in asymptomatic patients late after the Fontan procedure

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Clinical relevance of BNP measurement in the follow-up of patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Peptide hormones and their prohormones as biomarkers

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study.

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Ventricular expression of brain natriuretic peptide gene following orthotopic cardiac transplantation in children--a three year follow up

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

Elevated plasma B-type natriuretic peptide and C-reactive protein levels in children with restrictive right ventricular physiology following tetralogy of Fallot repair

1 reference

https://api.crossref.org/works/10.1017%2FS1047951114002133

7 January 2021

10.1017/S1047951114002133

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25601330%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference